Abstract
Nerve hydrodissection uses fluid injection under pressure to selectively separate nerves from areas of suspected entrapment; this procedure is increasingly viewed as potentially useful in treating carpal tunnel syndrome (CTS). The usage of normal saline (NS), 5% dextrose water (D5W), platelet-rich plasma (PRP), and hyaluronic acid (HA) as primary injectates for hydrodissection without an anesthetic can limit anesthetic-related toxicity and preserve the motor functions of the median nerve. Here, we describe a novel motor-sparing neural injection and compare the effect of these four injectates for severe CTS. We retrospectively reviewed the outcomes of 61 severe CTS cases after a single neural injection with NS, D5W, PRP, or HA. Outcomes were evaluated on the 1st and 6th months postinjection, including the Boston Carpal Tunnel Questionnaire (BCTQ) scores and the nerve cross-sectional area (CSA). The results revealed that PRP, D5W, and HA were more efficient than NS at all measured time points (p < 0.05), except for CSA at the 1st month between the NS and D5W groups. Single-injections of PRP and D5W seemed more effective than that of HA within 6 months postinjection for symptom and functional improvement (6th-month BCTQ-symptom, D5W vs. HA, p = 0.047; 1st-month BCTQ-symptom, PRP vs. HA, p = 0.018; 1st- and 6th-month BCTQ-function, D5W vs. HA, p = 0.002 and 0.016, respectively; 1st-month BCTQ-function, PRP vs. HA, p < 0.001). For reducing CSA, PRP and HA seemed more effective than D5W (HA > PRP > D5W on the 1st month and HA vs. D5W, p = 0.001; PRP > HA > D5W on the 6th month and PRP vs. D5W, p = 0.012).
Highlights
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy [1]
(c) For reducing crosssectional area (CSA), platelet-rich plasma (PRP) and hyaluronic acid (HA) seemed more effective than D5W
(b) Whether there is a cumulative effect of these injectates or not (c) The optimal dosage and frequency of these injections (d) The effect of these injections for subgroup patients who have higher risk for developing with CTS, e.g., uremia, diabetes mellitus, and rheumatoid arthritis (e) How about the clinical effect of these injections in patients with surgery failure or postsurgery recurrence?. These motor-sparing neural injections for CTS can prevent motor weakness or potential neuronal toxicity of CTS patients. Some of these neural injections were proven to be more effective than traditional conservative managements
Summary
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy [1]. The prevalence of CTS ranged from 1 to 5% with female predominantly [2]. Muscle atrophy at the thenar muscles with weakness may present [1]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.